Hi, it's Bob Safian. You've been hearing me as the host of rapid response in this feed for a few years now,

with short newsy interviews alongside the deeper dives of Masters of Scale. Well, I'm excited to share that rapid response is expanding into its own feed.

We'll be putting out shows twice a week, focusing on the urgent issues that business leaders are dealing with in real time.

So search for rapid response in your podcast player

and subscribe to make sure you get all our episodes.

I'll see you on the other side.

It is reported that over 9 million people living in the US are on weight loss drugs.

It's the talk of Tik-Tok.

Ozempik is a drug you inject that's meant to improve blood sugar and help manage type 2 diabetes.

But because one of the side effects is weight loss, many are using it off label, a

trend that may have started in Hollywood.

A drug shortage is impacting people living with diabetes and some pharmacies say they just can't get it in stop.

We are just getting started.

Millions of people are going to have seen the benefits.

Well then people are going to want to talk about what's

the cascading impact on society.

Look at the impact it's out on the grocery business or the restaurant business or travel or the

health care system, you name it.

You know, only a few million people have this this but 110 plus million people are eligible

there's a long way to go before we're done talking about this Bob Safian here. The boom in weight loss drugs like Ozempik and Wagovi is rippling across society and the business world.

Today I'm talking with Zach Ratano, CEO of Telehealth Platform Row, which has ridden the

weight loss craze to a $7 billion valuation.

...